Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wilkinson

Showing results (711-720 of 1,076) with videos related to

Pageof 108
Sort By:
The Journal of Clinical Investigation|August 4, 2010
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replicationRichard J Stanton, Katarina Baluchova, Derrick J Dargan, et al.
Neuron|July 1, 1996
Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesisNicholas W Gale, Sacha J Holland, David M Valenzuela, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2012
Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18Virginie Prod'homme, Peter Tomasec, Charles Cunningham, et al.
Translational Psychiatry|January 20, 2016
Epigenomic profiling of preterm infants reveals DNA methylation differences at sites associated with neural functionS Sparrow, J R Manning, J Cartier, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activationVirginia-Maria Vlachava, Sepehr Seirafian, Ceri A Fielding, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
EphB-ephrin-B2 interactions are required for thymus migration during organogenesisKatie E Foster, Julie Gordon, Kim Cardenas, et al.
Medical Microbiology and Immunology|April 21, 2015
Human cytomegalovirus: taking the strainGavin W G Wilkinson, Andrew J Davison, Peter Tomasec, et al.
Cell|June 7, 2014
Quantitative temporal viromics: an approach to investigate host-pathogen interactionMichael P Weekes, Peter Tomasec, Edward L Huttlin, et al.
Nature Immunology|January 11, 2005
Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141Peter Tomasec, Eddie C Y Wang, Andrew J Davison, et al.
The Journal of General Virology|May 19, 2010
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell cultureDerrick J Dargan, Elaine Douglas, Charles Cunningham, et al.
Pageof 108

Showing results (711-720 of 1,076) with videos related to

Sort By:
Pageof 108
The Journal of Clinical Investigation|August 4, 2010
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replicationRichard J Stanton, Katarina Baluchova, Derrick J Dargan, et al.
Neuron|July 1, 1996
Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesisNicholas W Gale, Sacha J Holland, David M Valenzuela, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2012
Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18Virginie Prod'homme, Peter Tomasec, Charles Cunningham, et al.
Translational Psychiatry|January 20, 2016
Epigenomic profiling of preterm infants reveals DNA methylation differences at sites associated with neural functionS Sparrow, J R Manning, J Cartier, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activationVirginia-Maria Vlachava, Sepehr Seirafian, Ceri A Fielding, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
EphB-ephrin-B2 interactions are required for thymus migration during organogenesisKatie E Foster, Julie Gordon, Kim Cardenas, et al.
Medical Microbiology and Immunology|April 21, 2015
Human cytomegalovirus: taking the strainGavin W G Wilkinson, Andrew J Davison, Peter Tomasec, et al.
Cell|June 7, 2014
Quantitative temporal viromics: an approach to investigate host-pathogen interactionMichael P Weekes, Peter Tomasec, Edward L Huttlin, et al.
Nature Immunology|January 11, 2005
Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141Peter Tomasec, Eddie C Y Wang, Andrew J Davison, et al.
The Journal of General Virology|May 19, 2010
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell cultureDerrick J Dargan, Elaine Douglas, Charles Cunningham, et al.
Pageof 108